RC
RadCall Procedure Guide
← Procedure Library
Procedure Playbook — Arterial Bleeding

Groin Pseudoaneurysm Management

Ultrasound-guided thrombin injection (first-line), compression repair, covered stent placement, or surgical referral for femoral artery pseudoaneurysms — most commonly iatrogenic following arterial catheterization.

Sedation
Local only (thrombin)
Bleeding Risk
Low (thrombin) · Moderate (stent)
Key Risk
Distal embolization · Recurrence · Skin compromise
Antibiotics
Not routine
Follow-up
Duplex US 24h · 1 week · 1 month
1

Indications & Treatment Methods

Patient selection, thrombin vs compression vs stent vs surgery

Indications for Treatment

  • Post-catheterization pseudoaneurysm — iatrogenic is the most common etiology (0.6–7.7% of femoral catheterizations)
  • Symptomatic — pain, expanding hematoma, pulsatile mass
  • >2 cm diameter — typically requires intervention (PSA <2 cm spontaneously thromboses in ~85% of cases)
  • Rapidly expanding or compromising overlying skin
  • Untreated PSA: high risk of rupture, thromboembolism, skin necrosis

Contraindications

  • Local infection at puncture site
  • Thrombin allergy (prior bovine thrombin exposure — anaphylaxis risk)
  • Concomitant AV fistula — thrombin injection is ineffective if significant AVF present; requires coil embolization or surgery
  • Severe distal limb ischemia — thrombin injection requires caution (embolization risk)
  • Relative: very wide neck PSA without ability to compress during injection

Treatment Method Decision Guide

MethodSuccess RateBest ForLimitations
US-guided thrombin injection (UGTI)95–100%First-line for most PSA; effective regardless of anticoagulation statusRisk of distal embolization; ineffective if AVF present
US-guided compression (UGCR)51–73% (anticoagulated); >90% (normal coag)Second-line; no thrombin requiredPainful; requires sedation; 4–6h supine; 20% recurrence
Covered stentHighThrombin failure, complex/multilobed PSA, wide-neck PSARequires arterial access; moderate bleeding risk
Surgical repairHighLarge PSA with pending rupture; significant hematoma requiring evacuationComplication rate up to 21%; requires OR
2

Pre-Procedure Planning

Duplex US confirmation, labs, anticoagulation management

Imaging & Diagnosis

  • Duplex US confirming PSA with characteristic to-and-fro flow (“yin-yang” sign) on color Doppler
  • Measure neck dimensions (length, width) and sac dimensions
  • Identify communication with CFA, SFA, or profunda femoris
  • Evaluate for AV fistula component (critical — thrombin ineffective if AVF present)
  • Distinguish from hematoma (no internal flow), true aneurysm, mycotic aneurysm

Patient Preparation

  • Hold anticoagulation if possible (although UGTI is successful regardless of anticoagulation status)
  • Labs: CBC, PT/INR, PTT if on heparin
  • Pre- and post-procedural ankle-brachial indices and pulse assessment
  • Local anesthesia only for thrombin injection (no sedation required)
  • Informed consent: discuss risk of distal embolization, recurrence, potential need for escalation
Duplex US completed. PSA confirmed with to-and-fro flow; neck and sac dimensions measured; parent artery (CFA/SFA/profunda) identified.
AV fistula excluded. No continuous high-velocity flow suggesting arteriovenous communication. If AVF present → consider coil embolization or surgical repair instead of thrombin.
Anticoagulation status reviewed. Hold if possible; note UGTI effective even in anticoagulated patients.
Consent obtained. Key risks discussed: distal embolization (rare), recurrence (5–10%), allergic reaction to bovine thrombin, potential need for covered stent or surgical repair.
Thrombin prepared. Topical thrombin (Thrombin-JMI) diluted to 1,000 IU/mL in normal saline; 1 mL syringe ready.
Baseline pulses and ABI documented. Pedal pulses palpated; ankle-brachial index recorded for comparison.
3

Relevant Anatomy

CFA, SFA, profunda femoris; PSA neck characteristics; differential diagnosis

Femoral Artery Anatomy

  • Common femoral artery (CFA) — continuation of external iliac artery below inguinal ligament; most common site of catheterization and PSA formation
  • Superficial femoral artery (SFA) — anterolateral continuation of CFA after bifurcation
  • Profunda femoris artery — posterolateral branch of CFA; PSA can arise from any of these vessels
  • PSA location relative to CFA bifurcation is critical for planning — influences neck access and compression approach

Pseudoaneurysm Characteristics

  • Neck — communication between parent artery and PSA sac; narrow neck = lower embolization risk during thrombin injection; wide neck = higher risk, may need compression or balloon protection
  • Sac — contained rupture of arterial wall; may be unilobed or multilobed
  • To-and-fro flow — systolic inflow into sac, diastolic outflow back to artery; pathognomonic on Doppler
  • “Yin-yang” sign — swirling bidirectional color flow within the sac on color Doppler

Differential Diagnosis

Hematoma: no internal flow on Doppler, no neck communication. AV fistula: continuous high-velocity turbulent flow between artery and vein, low-resistance arterial waveform. Mycotic (infected) aneurysm: true aneurysmal dilation of vessel wall with periarterial inflammation and gas; requires antibiotics and often surgical management. True aneurysm: involves all three layers of arterial wall (intima, media, adventitia); distinct from PSA where blood is contained only by extravascular tissue.

4

Technique

US-guided thrombin injection, compression, covered stent
1

US Assessment & Planning

High-MHz transducer with combined gray-scale and color Doppler imaging. Identify PSA sac, neck, and parent artery. Measure sac and neck dimensions. Confirm to-and-fro flow pattern. Plan needle trajectory into the sac apex, away from the neck. Evaluate for multilobed morphology.
Groin pseudoaneurysm — baseline ultrasound/angiogram
Groin pseudoaneurysm demonstrating characteristic to-and-fro flow adjacent to common femoral artery
Groin pseudoaneurysm at the CFA access site: saccular outpouching with characteristic bidirectional flow on Doppler — assess neck width and distance from CFA bifurcation.
2

Needle Placement

22–25G spinal needle placed under real-time US guidance into the PSA sac. Tip positioned at the apex of the pseudoaneurysm, pointing away from the neck. Gray-scale imaging used for needle placement; echogenic needle recommended for visualization. Maintain mild constant forward pressure on syringe plunger to prevent retrograde blood flow into needle tip.
3

Thrombin Injection

Switch to color Doppler imaging. Inject thrombin (100–1,000 IU, diluted to 1,000 IU/mL) slowly over ~10 seconds. Compress the neck gently with the US probe during injection. Monitor for echogenic thrombus formation and cessation of flow in real time. Slow injection rate as thrombus approaches the neck. Most PSAs thrombose within seconds. If partial thrombosis persists, advance needle several mm and reinject, or apply gentle compression for 2–4 minutes.
Thrombin injection under real-time ultrasound
Ultrasound-guided thrombin injection into pseudoaneurysm sac with needle visible in sac
Real-time US-guided thrombin injection: 22G needle in PSA sac — inject 1 mL (1000 U/mL) slowly while monitoring for sudden CFA flow loss.
4

Confirmation & Post-Procedure Check

Confirm complete thrombosis of PSA sac on color Doppler — no residual flow. Verify patency of parent artery (CFA/SFA/profunda). Check distal pedal pulses and ABI. Patients may ambulate immediately. Follow-up duplex US at 24 hours, 1 week, and 1 month.
Post-injection — PSA excluded, CFA patent
Post-thrombin injection ultrasound demonstrating pseudoaneurysm thrombosis with patent common femoral artery
Post-thrombin injection: PSA sac thrombosed with no residual flow — confirm CFA patency with Doppler before completing procedure.

Alternative Techniques (If Thrombin Fails or Complex PSA)

  • Covered stent placement: for multilobed PSA, wide-neck PSA, or thrombin injection failure. Arterial access via contralateral femoral approach; covered stent deployed across the PSA neck to exclude the sac. Moderate bleeding risk.
  • US-guided compression repair (UGCR): second-line option. Compress PSA neck under US guidance until flow ceases; maintain 20–30 min. Painful; requires sedation. Lower success rate (51–73% in anticoagulated patients). Not effective for suprainguinal or post-operative PSA.
  • Surgical repair: for large PSA with pending rupture, significant hematoma requiring evacuation, failed percutaneous treatment. Complication rate up to 21% (MI, death, bleeding, lymphocele, infection).

Community Cards

Browse Card Library →
Sign in to view and create community cards
5

Ultrasound Landmarks

PSA sac, neck, parent artery identification on color Doppler

Key US Findings

  • Gray-scale: hypoechoic/anechoic fluid collection adjacent to femoral artery; may see layered thrombus within sac
  • Color Doppler “yin-yang” sign: swirling bidirectional color flow within the PSA sac — pathognomonic
  • Spectral Doppler at neck: characteristic to-and-fro waveform — systolic inflow into sac, diastolic outflow back to artery
  • Neck visualization: narrow channel connecting sac to parent artery; measure length and width

Needle Placement Landmarks

  • Target needle tip at the apex (far wall) of the PSA sac, away from the neck
  • Inject into the region where flow is directed away from the neck on color Doppler
  • For multilobed PSA: inject the most superficial lobe first; if other lobes do not thrombose, inject each separately
  • Compress the neck with the US probe during injection to prevent thrombin reflux into parent artery
6

Troubleshooting

Intraoperative problems and solutions
Critical

Thrombin Into Parent Artery — Limb-Threatening

If thrombin enters the native femoral artery, distal thrombosis and limb ischemia can result. Prevention: always inject into the sac center/apex, never near the neck. Compress neck during injection. Use slow injection rate and stop immediately if thrombus is seen extending toward the neck. Treatment: emergent catheter-directed thrombolysis with TPA or surgical thrombectomy. Check distal pulses immediately after every injection.

Multilobed PSA

Multiple Communicating Sac Lobes

Inject the most superficial lobe first under US guidance. If other lobes do not thrombose spontaneously, perform additional targeted injections into each lobe separately. Multilobed PSA may ultimately require covered stent if thrombin injection fails to thrombose all lobes.

Wide Neck PSA

Large Neck Communication Increases Embolization Risk

Compress neck firmly with US probe during thrombin injection. Consider placing an endovascular balloon via contralateral access to protect the native artery during injection. If wide neck prevents safe thrombin injection, proceed to covered stent placement.

Recurrence

PSA Recurs After Thrombin Injection

Recurrence rate after UGTI is approximately 5–10%. Repeat thrombin injection can be performed (note: increased embolization risk with re-treatment of persistent necks). ~66% of persistent necks regress spontaneously. If repeat thrombin injection fails, escalate to covered stent placement or surgical repair.

AV Fistula Component

Concomitant Arteriovenous Fistula Detected

Thrombin injection is ineffective if a significant AV fistula is present (continuous high-velocity flow prevents thrombosis). Requires concomitant coil embolization of the fistulous tract, covered stent, or surgical repair. Always evaluate for AVF on duplex US before proceeding with thrombin injection.

7

Complications

Overall complication rate for UGTI <1%

Serious Complications

  • Distal embolization — thrombin entering parent artery causing downstream thrombosis; rare but limb-threatening; treat with catheter-directed TPA or surgical thrombectomy
  • Anaphylaxis to bovine thrombin — reported in patients with prior bovine thrombin exposure; avoid re-exposure; consider human thrombin alternative
  • Nontarget arterial thrombosis — intraluminal clot propagation from PSA into femoral artery; may resolve spontaneously or require intervention

Minor Complications & Expected Outcomes

  • Recurrence (5–10%) — PSA re-establishes flow after initial thrombosis; repeat UGTI or escalate
  • Transient loss of distal pulse — may occur and typically returns within 24h; monitor closely
  • Local infection / abscess — rare; one case report of abscess requiring I&D
  • Soleal vein thrombosis — reported rarely; monitor for DVT symptoms
  • Persistent hematoma — thrombosed PSA sac remains palpable; resolves over weeks
8

Pearls & Pitfalls

High-yield tips for successful management
Thrombin injection success rate is 95–100% in published series. UGTI is the clear first-line treatment for femoral PSA — it is fast (procedure completed in ~5 minutes), cost-effective (<$5 per vial), and does not require sedation.
Inject thrombin slowly into the sac center/apex, NOT near the neck. Position needle tip at the far wall of the sac where flow is directed away from the neck. This minimizes risk of thrombin entering the parent artery.
Compress the PSA neck with the ultrasound probe during thrombin injection. This prevents thrombin reflux into the native artery and improves thrombosis efficiency. Avoid firm manual compression after thrombosis — squeezing new thrombus into the vessel is hazardous.
Always check for AV fistula before thrombin injection. Thrombin is ineffective if an AVF is present. Look for continuous turbulent flow on Doppler between artery and vein. If AVF is found, manage with coil embolization or surgery.
Small PSA (<2 cm) may thrombose spontaneously in ~85% of cases. Observe with serial duplex US before intervening. Reserve UGTI for PSA >2 cm, symptomatic, or expanding.
UGTI is successful regardless of anticoagulation status — patients do not need to discontinue aspirin, clopidogrel, enoxaparin, or warfarin for the procedure.
Do NOT inject thrombin near the PSA neck. Thrombin entering the parent artery can cause distal embolization and limb ischemia. If thrombus is seen approaching the neck on US, stop injection immediately.
Avoid bovine thrombin in previously exposed patients. Anaphylaxis has been reported. Use human thrombin (recombinant) as an alternative in patients with prior bovine thrombin exposure.
Do NOT apply firm compression after successful thrombosis. This can squeeze fresh thrombus out of the sac into the native artery. Gentle probe pressure during injection only.
9

References & Resources

Primary sources and evidence

Primary References

  • Krueger K, Zaehringer M, Strohe D, et al. Postcatheterization pseudoaneurysm: results of US-guided percutaneous thrombin injection in 240 patients. J Vasc Interv Radiol. 2005;16(1):57–62.
  • Morgan R, Belli AM. Current treatment methods for postcatheterization pseudoaneurysms. J Vasc Interv Radiol. 2003;14(6):697–710.
  • Padidar AM, Kee ST, Razavi MK. Treatment of femoral artery pseudoaneurysms using ultrasound-guided thrombin injection. Tech Vasc Interv Radiol. 2003;6(2):96–102.
  • Kang SS, Labropoulos N, Mansour MA, et al. Percutaneous ultrasound guided thrombin injection: a new method for treating postcatheterization femoral pseudoaneurysms. J Vasc Surg. 1998;28:1120–1121.
  • Paulson EK, Nelson RC, Mayes CE, et al. Sonographically guided thrombin injection of iatrogenic femoral pseudoaneurysms: further experience of a single institution. Am J Roentgenol. 2001;177:309–316.
  • Pezzullo JA, Dupuy DE, Cronan JJ. Percutaneous injection of thrombin for the treatment of pseudoaneurysms after catheterization. Am J Roentgenol. 2000;175:1035–1040.